Bloom Tree Partners’s LumiraDx Limited Warrant LMDXW Stock Holding History

Bloom Tree Partners’s Portfolio LMDXW Stock Details LMDXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$307	Hold	10,255	–	–	﹤0.01%	43
2023 Q1	$872	Hold	10,255	–	–	﹤0.01%	46
2022 Q4	$605	Hold	10,255	–	–	﹤0.01%	45
2022 Q3	$1K	Hold	10,255	–	–	﹤0.01%	68
2022 Q2	$9K	Hold	10,255	–	–	﹤0.01%	93
2022 Q1	$9K	Sell	10,255 -2,236	-18%	-$2.88K	﹤0.01%	115
2021 Q4	$23K	Hold	12,491	–	–	﹤0.01%	121
2021 Q3	$15K	Buy	+12,491	New	+$14.5K	﹤0.01%	162

Other funds holding LMDXW

CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Covalent Partners Concord, Massachusetts $17.6M AUM 2.91% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Bloom Tree Partners's LMDXW Position: Q2 2023 in Review

Bloom Tree Partners held its LumiraDx Limited Warrant (LMDXW) position steady in Q2 2023 at 10,255 shares worth $307. The position accounts for ﹤0.01% of the portfolio, ranked #43.

Bloom Tree Partners first reported a position in LMDXW in Q3 2021 and has held it in 8 quarters since. The position peaked at $23K in Q4 2021. 17 funds tracked by Wall St. Rank hold LMDXW as of Q2 2023.

Bloom Tree Partners held 10,255 shares of LumiraDx Limited Warrant worth $307 as of Q2 2023.
Bloom Tree Partners left its LumiraDx Limited Warrant share count unchanged in Q2 2023.
LumiraDx Limited Warrant made up ﹤0.01% of Bloom Tree Partners's portfolio in Q2 2023, its #43 holding.
Bloom Tree Partners first reported a position in LumiraDx Limited Warrant in Q3 2021 and has held it in 8 quarters since.
Bloom Tree Partners's LumiraDx Limited Warrant position peaked at $23K in Q4 2021.
17 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q2 2023.

Based on Bloom Tree Partners's 13F filing for Q2 2023, filed 11 Aug 2023.